{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T12:50:41Z","timestamp":1784033441069,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["176\/2017\/A3"],"award-info":[{"award-number":["176\/2017\/A3"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Fund of University of Macau","award":["MYRG2018-00165-ICMS"],"award-info":[{"award-number":["MYRG2018-00165-ICMS"]}]},{"name":"Research Fund of University of Macau","award":["CPG2019-00006-ICMS"],"award-info":[{"award-number":["CPG2019-00006-ICMS"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.fct.2019.05.045","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T11:22:45Z","timestamp":1559042565000},"page":"110537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells"],"prefix":"10.1016","volume":"131","author":[{"given":"Mu-Yang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo-Wei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run-Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9539-2005","authenticated-orcid":false,"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2675-7645","authenticated-orcid":false,"given":"Xiuping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-3120","authenticated-orcid":false,"given":"Jin-Jian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.fct.2019.05.045_bib1","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1200\/JCO.2016.71.6795","article-title":"Avelumab, an anti-programmed death-ligand 1 antibody, in patients with refractory metastatic urothelial carcinoma: results from a multicenter, phase Ib study","volume":"35","author":"Apolo","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.fct.2019.05.045_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1078\/0065-1281-00534","article-title":"Hemolysis of human erythrocytes with saponin affects the membrane structure","volume":"102","author":"Baumann","year":"2000","journal-title":"Acta Histochem."},{"issue":"1","key":"10.1016\/j.fct.2019.05.045_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12185-014-1605-z","article-title":"Effect of saponin on erythrocytes","volume":"100","author":"Bissinger","year":"2014","journal-title":"Int. J. Hematol."},{"issue":"17","key":"10.1016\/j.fct.2019.05.045_bib4","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"7670","key":"10.1016\/j.fct.2019.05.045_bib5","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature."},{"issue":"7718","key":"10.1016\/j.fct.2019.05.045_bib6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature."},{"issue":"9","key":"10.1016\/j.fct.2019.05.045_bib7","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1172\/JCI80011","article-title":"Anti-PD-1\/PD-L1 therapy of human cancer: past, present, and future","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.fct.2019.05.045_bib8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.intimp.2015.04.001","article-title":"Protective effect of platycodin D on liver injury in alloxan-induced diabetic mice via regulation of Treg\/Th17 balance","volume":"26","author":"Chen","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.fct.2019.05.045_bib9","doi-asserted-by":"crossref","first-page":"7918034","DOI":"10.1155\/2018\/7918034","article-title":"Effects of platycodin D on reflux esophagitis due to modulation of antioxidant defense systems","author":"Cho","year":"2018","journal-title":"Evid. Based Complement Altern. Med."},{"issue":"5","key":"10.1016\/j.fct.2019.05.045_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/13543776.2016.1176150","article-title":"Immune checkpoint inhibitors: a patent review (2010-2015)","volume":"26","author":"Collin","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.fct.2019.05.045_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.biopha.2018.08.082","article-title":"Platycodin D protects acetaminophen-induced hepatotoxicity by inhibiting hepatocyte mapk pathway and apoptosis in C57BL\/6j mice","volume":"107","author":"Fu","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.fct.2019.05.045_bib12","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/bjc.2015.124","article-title":"Anti-programmed cell death protein-1\/ligand-1 therapy in different cancers","volume":"112","author":"Homet Moreno","year":"2015","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.fct.2019.05.045_bib13","first-page":"644","article-title":"Protective effects of platycodin D on lipopolysaccharide-induced acute lung injury by activating lxralpha-abca1 signaling pathway","volume":"7","author":"Hu","year":"2016","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.fct.2019.05.045_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13020-018-0192-y","article-title":"Anticancer drug discovery from Chinese medicinal herbs","volume":"13","author":"Huang","year":"2018","journal-title":"Chin. Med."},{"issue":"11","key":"10.1016\/j.fct.2019.05.045_bib15","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/aps.2017.123","article-title":"Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells","volume":"38","author":"Jiang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.fct.2019.05.045_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.fct.2018.11.001","article-title":"Platycodi radix and its active compounds ameliorate against house dust mite-induced allergic airway inflammation and ER stress and ROS by enhancing anti-oxidation","volume":"123","author":"Lee","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2019.05.045_bib17","doi-asserted-by":"crossref","first-page":"12632","DOI":"10.1038\/ncomms12632","article-title":"Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity","volume":"7","author":"Li","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.fct.2019.05.045_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.7314\/APJCP.2014.15.4.1745","article-title":"Platycodin D induces apoptosis, and inhibits adhesion, migration and invasion in HepG2 hepatocellular carcinoma cells","volume":"15","author":"Li","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"12","key":"10.1016\/j.fct.2019.05.045_bib19","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/aps.2015.99","article-title":"Platycodin D induces apoptosis and triggers ERK- and JNK-mediated autophagy in human hepatocellular carcinoma BEL-7402 cells","volume":"36","author":"Li","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.fct.2019.05.045_bib20","doi-asserted-by":"crossref","first-page":"37997","DOI":"10.1038\/srep37997","article-title":"Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2019.05.045_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.taap.2017.07.006","article-title":"Novel Hsp90 inhibitor platycodin D disrupts Hsp90\/Cdc37 complex and enhances the anticancer effect of mTOR inhibitor","volume":"330","author":"Li","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.fct.2019.05.045_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ccell.2016.10.010","article-title":"Deubiquitination and stabilization of PD-L1 by CSN5","volume":"30","author":"Lim","year":"2016","journal-title":"Cancer Cell."},{"issue":"5","key":"10.1016\/j.fct.2019.05.045_bib23","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.febslet.2009.01.048","article-title":"Release of extracellular membrane vesicles from microvilli of epithelial cells is enhanced by depleting membrane cholesterol","volume":"583","author":"Marzesco","year":"2009","journal-title":"FEBS Lett."},{"issue":"26","key":"10.1016\/j.fct.2019.05.045_bib24","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1200\/JCO.2016.67.9761","article-title":"Safety and efficacy of durvalumab (MEDI4736), an anti-programmed cell death ligand-1 immune checkpoint inhibitor, in patients with advanced urothelial bladder cancer","volume":"34","author":"Massard","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"7670","key":"10.1016\/j.fct.2019.05.045_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.fct.2019.05.045_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.fct.2019.05.045_bib27","first-page":"180","article-title":"Opdivo (nivolumab): second PD-1 inhibitor receives FDA approval for unresectable or metastatic melanoma","volume":"8","author":"Raedler","year":"2015","journal-title":"Am. Health Drug Benefit."},{"issue":"10066","key":"10.1016\/j.fct.2019.05.045_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0140-6736(16)32517-X","article-title":"Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial","volume":"389","author":"Rittmeyer","year":"2017","journal-title":"The Lancet."},{"issue":"26","key":"10.1016\/j.fct.2019.05.045_bib29","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma","volume":"372","author":"Robert","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.fct.2019.05.045_bib30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.immuni.2018.03.014","article-title":"Regulation and function of the PD-L1 checkpoint","volume":"48","author":"Sun","year":"2018","journal-title":"Immunity."},{"issue":"1","key":"10.1016\/j.fct.2019.05.045_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1749-8546-9-16","article-title":"Platycodin D from platycodonis radix enhances the anti-proliferative effects of doxorubicin on breast cancer MCF-7 and MDA-MB-231 cells","volume":"9","author":"Tang","year":"2014","journal-title":"Chin. Med."},{"key":"10.1016\/j.fct.2019.05.045_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ejphar.2017.07.037","article-title":"Platycodin D suppressed LPS-induced inflammatory response by activating lxralpha in LPS-stimulated primary bovine mammary epithelial cells","volume":"814","author":"Wang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fct.2019.05.045_bib33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ejmech.2018.01.011","article-title":"Hepatoprotective natural triterpenoids","volume":"145","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"3\u20134","key":"10.1016\/j.fct.2019.05.045_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0304-4157(85)90011-5","article-title":"Cholesterol and the cell membrane","volume":"822","author":"Yeagle","year":"1985","journal-title":"Biochim. Biophys. Acta Rev. Biomembr."},{"issue":"9","key":"10.1016\/j.fct.2019.05.045_bib35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/13543776.2016.1206527","article-title":"Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)","volume":"26","author":"Zarganes-Tzitzikas","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.fct.2019.05.045_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejphar.2018.04.020","article-title":"Downregulation of cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells","volume":"830","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fct.2019.05.045_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jep.2015.01.052","article-title":"Platycodon grandiflorus - an ethnopharmacological, phytochemical and pharmacological review","volume":"164","author":"Zhang","year":"2015","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.fct.2019.05.045_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat. Rev. Canc."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691519303126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691519303126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:51:08Z","timestamp":1759528268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691519303126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":38,"alternative-id":["S0278691519303126"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2019.05.045","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2019.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110537"}}